California State Teachers Retirement System (CalSTRS)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,342	Closed	-$37K	–	3387
2022 Q1	$37K	Sell	13,342 -3,127	-19%	-$9.84K	﹤0.01%	3104
2021 Q4	$77K	Sell	16,469 -20,299	-55%	-$127K	﹤0.01%	3072
2021 Q3	$313K	Sell	36,768 -5,293	-13%	-$74.8K	﹤0.01%	2587
2021 Q2	$690K	Sell	42,061 -1,598	-4%	-$32.3K	﹤0.01%	2453
2021 Q1	$964K	Buy	43,659 +5,211	+14%	+$142K	﹤0.01%	2164
2020 Q4	$1.19M	Hold	38,448	–	–	﹤0.01%	1932
2020 Q3	$781K	Buy	38,448 +13,887	+57%	+$244K	﹤0.01%	2010
2020 Q2	$377K	Buy	24,561 +6,098	+33%	+$70.3K	﹤0.01%	2391
2020 Q1	$143K	Buy	18,463 +209	+1%	+$2.56K	﹤0.01%	2697
2019 Q4	$261K	Hold	18,254	–	–	﹤0.01%	2683
2019 Q3	$274K	Buy	18,254 +15,522	+568%	+$242K	﹤0.01%	2650
2019 Q2	$39K	Buy	+2,732	New	+$43.6K	﹤0.01%	3017

Other funds holding TCRR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s TCRR Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2022, closing a stake of 13,342 shares — an estimated $37K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in TCRR in Q2 2019 and held it in 12 quarters. The position peaked at $1.19M in Q4 2020. 83 funds tracked by Wall St. Rank hold TCRR as of Q2 2022.

California State Teachers Retirement System (CalSTRS) reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 13,342 TCR2 Therapeutics Inc. Common Stock shares in Q2 2022, an estimated $37K.
California State Teachers Retirement System (CalSTRS) first reported a position in TCR2 Therapeutics Inc. Common Stock in Q2 2019 and held it in 12 quarters.
California State Teachers Retirement System (CalSTRS)'s TCR2 Therapeutics Inc. Common Stock position peaked at $1.19M in Q4 2020.
83 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.